LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder.

Dimitri Daldegan-BuenoCarina Joy DoneganAnna ForsythRachael Louise SumnerRobin J MurphyDavid B MenkesWilliam EvansNicholas R HoehFrederick SundramLisa M ReynoldsRhys PontonAlana CavadinoTodd SmithPartha RoopNathan AllenBinu AbeysingheDarren SvirskisMahima BansalSuresh Muthukumaraswamy

Published in: Trials (2024)

ANZCTR, ACTRN12624000128594. Prospectively Registered on 13 February 2024.

Keyphrases

major depressive disorder
placebo controlled
phase iii
phase ii
double blind
study protocol
bipolar disorder
clinical trial
open label
phase ii study
randomized controlled trial
molecularly imprinted
squamous cell carcinoma
high resolution
radiation therapy
locally advanced